As per the report published by Market Research Future (MRFR) Global Periodontal Therapeutic Market Research Report: By Type (Chronic Periodontitis Aggressive Periodontitis and Necrotizing Periodontal), by Treatment (Systematic Antibiotics and Others), by End-Users (Dental Hospital and Others)—Forecast Till 2023
Key Players
Some of the key players in the global periodontal therapeutic market are, Tolmar Inc, Eli Lilly & Company, Align Technology Inc., Dentsply International, 3M-ESPE, Ultradent Products Inc., Nobel Biocare Holdings AG, Glidewell Laboratories, Inc., Orapharma, Kaken Pharmaceutical, Valeant Pharmaceuticals Int. Inc, Den-Mat Holdings, Mallinckrodt Pharmaceuticals, Purdue Pharma L.P., Teva Pharmaceutical Industries Limited, and Fibrocell Sciences Inc.
Market Highlights
The Global Periodontal Therapeutic Market Is Expected To Grow Significantly Over The Forecast Period. It Is Estimated That The Global Periodontal Therapeutic Market Is Expected To Register A CAGR Of ~ 9.2 % During The Forecast Period From 2018 To 2023.
Periodontal disease is an infection that occurs around the teeth which include gums, periodontal ligament and alveolar bone. The earliest stage of periodontal is gingivitis infection that affects the gums. Periodontal is mostly caused by bacteria in dental plaque sticky substance that forms on teeth. Although bacterial plaque is the main cause of periodontal disease several other factors such as medication, other diseases, and oral habit also contributes to periodontal disease.
The increasing demand for local antibiotic has resulted in a rise in research and development of local antibiotic. Owing to the increasing incidences of diabetic patients there is a rise in the periodontal therapeutic market. Whereas the rising prevalence of periodontal disorders and technological advancement in therapeutics are some factors positively impacting on the growth of this market. By segment systemic antibiotic will holds the largest share of the market during the forecast period.
Whereas local antibiotic segment is expected to grow at the fastest rate due to decreasing chances of formation of resistant bacteria following few side effects. Increasing expenditure on oral health care services by the government especially in developed countries is anticipated to boost the treatment market for the periodontal disorder.
However, the lack of reimbursement policies in various countries across the world may limit the growth of this market in the forecast period.
Ask for free Sample: https://www.marketresearchfuture.com/sample_request/6562
Segmentation
The global periodontal therapeutic market has been segmented on basis of treatment type, types of periodontal and end-users. Based on treatment types market is segmented into two segments such as systematic antibiotics and local antibiotics. Systematic antibiotics are further sub-segmented into doxycycline, minocycline, metronidazole, and others. Local antibiotics are further segmented into arestin, chlorhexidine, and others. On basis of types of periodontal, the market is segmented into three types such as chronic periodontitis, aggressive periodontitis, necrotizing periodontal disease. On basis of end-user market is further is segmented into dental clinics and hospitals
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
Regional Analysis
A booming need for more oral hygiene appeal in the field of periodontal treatment is being observed worldwide. The rising awareness regarding oral hygiene and increasing incidence of the periodontal disorder among people are factors responsible for the growth of the market in this region.
The market in the Americas is expected to boost the global periodontal therapeutic market owing to technological advancement and increasing incidences of the periodontal disorder among diabetic patients. According to recent findings from the Centers for Disease Control and Prevention (CDC), half of Americans aged 30 or older have periodontitis, the more advanced form of periodontal disease. This equals approximately 64.7 million Americans. This is largely attributed to the accessibility of an urban healthcare infrastructure.
The European market is expected to be the second-largest due to government funding and support from the healthcare sector coupled with the rising prevalence of the periodontal disorder. However, Asia-Pacific is projected to dominate in terms of growth rate over the forecast period owing to rising investment towards R&D activities and unhealthy lifestyle which are resulting in an increased prevalence of obesity. Rising geriatric population and the increasing prevalence of diabetes in this region have a positive influence on the development of the periodontal therapeutic market in this region.
The Middle East and Africa account for the smallest share due to lack of medical technology and poor medical facilities. Emerging economies such as India and China are leading to growth in demand for periodontal therapeutic owing to increasing number of healthcare awareness programs, government investment in healthcare and favorable healthcare insurance coverage. National Oral Health Programmed (NOHP) was conceptualized by the Indian Dental Association to ensure optimal oral health for all by increasing awareness, assuring excellent service and high-quality dental care.
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Periodontal Therapeutic Market, By Types
6.1 Introduction
6.2 Gingivitis
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.3 Chronic Periodontitis
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.4 Aggressive Periodontitis
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
6.5 Necrotizing Periodontal
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
Chapter 7. Global Periodontal Therapeutic Market, By Treatment
7.1 Introduction
7.2 Systematic Antibiotics
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.2.1 Doxycycline
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.2.2 Minocycline
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.2.3 Metronidazole
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.2.4 Others
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
7.3 Local Antibiotics
Chapter 8. Global Periodontal Therapeutic Market, By End-Users
8.1 Introduction
8.2 Dental Clinic
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–202
8.3 Hospitals
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
8.4 Others
Market Estimates & Forecast, By Region, 2018–2023
Market Estimates & Forecast, By Country, 2018–2023
Chapter 9. Global Periodontal Therapeutic Market, By Region
9.1 Introduction
9.2 America
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
Chapter 11. Company Profiles
11.1 Fibrocell Sciences, Inc
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Tolmar Inc
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Eli Lilly & Company
11.3.1 Company Overview
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s Viewpoint
12.1.2 Unmet Needs Of The Market
12.2 Key Companies To Watch
12.3 Predictions For The Global Periodontal Therapeutic Industry
Chapter 13. Appendix
LIST OF TABLES
Table 1 Global Periodontal Therapeutic Market Synopsis, 2018–2023
Table 2 Global Periodontal Therapeutic Market Estimates And Forecast, 2018–2023 (USD Million)
Table 3 Global Periodontal Therapeutic Market, By Types, 2018–2023 (USD Million)
Table 4 Global Periodontal Therapeutic Market, By Treatment, 2018–2023 (USD Million)
Table 5 Global Periodontal Therapeutic Market, By End-User, 2018–2023 (USD Million)
Table 6 Global Periodontal Therapeutic Market, By Region, 2018–2023(USD Million)
Table 7 North America: Periodontal Therapeutic Market, By Types, 2018–2023 (USD Million)
Table 8 North America: Periodontal Therapeutic Market, By Treatment, 2018–2023 (USD Million)
Table 9 North America: Periodontal Therapeutic Market, By End-User, 2018–2023 (USD Million)
Table 10 North America: Periodontal Therapeutic Market, By Region, 2018–2023 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Global Periodontal Therapeutic Market
Figure 3 Segmentation Market Dynamics For Global Periodontal Therapeutic Market
Figure 4 Global Periodontal Therapeutic Market Share, By Types, 2018(%)
Figure 5 Global Periodontal Therapeutic Market Share, By Treatment, 2018(%)
Figure 6 Global Periodontal Therapeutic Market Share, By End-User, 2018(%)
Figure 7 Global Periodontal Therapeutic Market Share, By Region, 2018(%)
Figure 8 North America: Periodontal Therapeutic Market Share, By Country, 2018(%)
Figure 9 Europe: Periodontal Therapeutic Market Share, By Country, 2018(%)
Figure 10 Asia-Pacific: Periodontal Therapeutic Market Share, By Country, 2018(%)
Figure 11 Middle East & Africa: Periodontal Therapeutic Market Share, By Country, 2018(%)
Figure 12 Global Periodontal Therapeutic Market: Company Share Analysis, 2018(%)
Figure 13 Fibrocell Sciences, Inc: Key Financials
Figure 14 Fibrocell Sciences, Inc: Segmental Revenue
Figure 15 Fibrocell Sciences, Inc: Geographical Revenue
Figure 16 Tolmar Inc: Key Financials
Continued…
Access Report @ https://www.marketresearchfuture.com/reports/periodontal-therapeutic-market-6562
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312